Tunneling nanotubes between neurons enable the spread of Parkinson's disease via lysosomes

Tunneling nanotubes between neurons enable the spread of Parkinson's disease via lysosomes
Credit: Institut Pasteur

Scientists from the Institut Pasteur have demonstrated the role of lysosomal vesicles in transporting α-synuclein aggregates, responsible for Parkinson's and other neurodegenerative diseases, between neurons. These proteins move from one neuron to the next in lysosomal vesicles which travel along the "tunneling nanotubes" between cells. These findings were published in The EMBO Journal on Aug. 22, 2016.

Synucleinopathies, a group of including Parkinson's , are characterized by the pathological deposition of of the misfolded α-synuclein protein into inclusions throughout the central and peripheral nervous system. Intercellular propagation (from one neuron to the next) of α-synuclein aggregates contributes to the progression of the neuropathology, but little was known about the mechanism by which spread occurs.

In this study, scientists from the Membrane Traffic and Pathogenesis Unit, directed by Chiara Zurzolo at the Institut Pasteur, used fluorescence microscopy to demonstrate that pathogenic α-synuclein travel between neurons in culture, inside lysosomal vesicles through tunneling nanotubes (TNTs), a new mechanism of intercellular communication.

After being transferred via TNTs, α-synuclein fibrils are able to recruit and induce aggregation of the soluble α-synuclein protein in the cytosol of cells receiving the fibrils, thus explaining the propagation of the disease. The scientists propose that cells overloaded with α-synuclein aggregates in lysosomes dispose of this material by hijacking TNT-mediated intercellular trafficking. However, this results in the disease being spread to naive neurons.

This study demonstrates that TNTs play a significant part in the intercellular transfer of α-synuclein fibrils and reveals the specific role of lysosomes in this process. This represents a major breakthrough in understanding the mechanisms underlying the progression of synucleinopathies.

These compelling findings, together with previous reports from the same team, point to the general role of TNTs in the propagation of prion-like proteins in neurodegenerative diseases and identify TNTs as a new therapeutic target to combat the progression of these incurable diseases.


Explore further

Discovery may lead to a treatment to slow Parkinson's disease

More information: Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes, The EMBO Journal, 22 August 2016, DOI: 10.15252/embj.201593411
Journal information: EMBO Journal

Provided by Institut Pasteur
Citation: Tunneling nanotubes between neurons enable the spread of Parkinson's disease via lysosomes (2016, August 22) retrieved 16 May 2021 from https://medicalxpress.com/news/2016-08-tunneling-nanotubes-neurons-enable-parkinson.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments